Joint device reviews with Canada and Japan could be considered, FDA's Horton says.
This article was originally published in The Gray Sheet
Executive Summary
FDA JOINT DEVICE REVIEWS WITH CANADA, JAPAN could be considered by the agency, Linda Horton, Director of FDA's International Policy office, said March 26 at the 6th Annual International Standards Conference on Medical Devices in Reston, Virginia. Countries such as Canada and Japan, which maintain a government role in premarket review of devices, could be candidates for collaborative reviews with FDA, Horton indicated.